VIROPHARMA INC (VPHM) financial statements (2021 and earlier)

Company profile

Business Address 730 STOCKTON DRIVE
EXTON, PA 19341
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments275259261 
Cash and cash equivalents206191199 
Short-term investments706762 
Receivables615658 
Inventory, net of allowances, customer advances and progress billings1008873
Inventory1008873 
Prepaid expense17  
Prepaid expense and other current assets1925 
Deferred tax assets131815 
Other undisclosed current assets282824 
Total current assets:495469457 
Noncurrent Assets
Property, plant and equipment141211 
Intangible assets, net (including goodwill)586591600
Goodwill979696 
Intangible assets, net (excluding goodwill)490494504 
Deferred costs222 
Other noncurrent assets21  
Prepaid expense and other noncurrent assets2020 
Deferred tax assets, net192018 
Total noncurrent assets:642645651 
TOTAL ASSETS:1,1361,1131,108 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities929093 
Accounts payable161617 
Accrued liabilities767375 
Taxes payable001 
Other undisclosed current liabilities  8 
Total current liabilities:9290101 
Noncurrent Liabilities
Long-term debt and lease obligation337332328 
Long-term debt, excluding current maturities337332328 
Liabilities, other than long-term debt116120124 
Deferred tax liabilities, net116120123 
Other liabilities001 
Other undisclosed noncurrent liabilities(136)(139)(146) 
Total noncurrent liabilities:317314307 
Total liabilities:408403407 
Stockholders' equity
Stockholders' equity attributable to parent728710701 
Common stock000 
Treasury stock, value(350)(350)(350) 
Additional paid in capital820807798 
Accumulated other comprehensive loss(3)(4)(3) 
Retained earnings261257256 
Total stockholders' equity:728710701 
TOTAL LIABILITIES AND EQUITY:1,1361,1131,108 

Income statement (P&L) ($ in millions)

9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Revenues
(Revenue, Net)
113104107 
Cost of revenue
(Cost of Goods and Services Sold)
(27)(28)(30) 
Gross profit:867677 
Operating expenses(75)(72)(175) 
Operating income (loss):114(98) 
Nonoperating income (expense)4(0)(4) 
Investment income, nonoperating000 
Other nonoperating income (expense)4(0)(4) 
Interest and debt expense(4)(4)(4) 
Income (loss) from continuing operations before income taxes:11(0)(105) 
Income tax expense (benefit)(6)141 
Net income (loss) available to common stockholders, diluted:41(64) 

Comprehensive Income ($ in millions)

9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Net income (loss):41(64) 
Comprehensive income (loss):41(64) 
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1(0)(1) 
Comprehensive income (loss), net of tax, attributable to parent:50(65) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: